BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/20/2023 7:26:29 AM | Browse: 153 | Download: 464
Publication Name World Journal of Hepatology
Manuscript ID 81125
Country China
Received
2022-10-26 12:24
Peer-Review Started
2022-10-26 12:26
To Make the First Decision
Return for Revision
2022-11-28 10:33
Revised
2023-02-14 13:12
Second Decision
2023-03-28 03:30
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2023-03-29 08:04
Articles in Press
2023-03-29 08:04
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2023-04-17 01:42
Publish the Manuscript Online
2023-04-20 07:26
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Minireviews
Article Title Ablative strategies for recurrent hepatocellular carcinoma
Manuscript Source Invited Manuscript
All Author List Lin Wang, Bao-Xian Liu and Hai-Yi Long
ORCID
Author(s) ORCID Number
Bao-Xian Liu http://orcid.org/0000-0002-6841-1637
Hai-Yi Long http://orcid.org/0000-0001-5158-5879
Funding Agency and Grant Number
Corresponding Author Hai-Yi Long, MD, Doctor, Department of Medical Ultrasound, Institute of Diagnostic and Interventional Ultrasound, the First Affiliated Hospital of SunYat-sen University, No. 58 Zhongshan Road 2, Guangzhou 510080, Guangdong Province, China. longhy9@mail.sysu.edu.cn
Key Words Hepatocellular carcinoma; Recurrence; Ablative therapy; Thermal ablation
Core Tip Despite the tremendous efforts in the fight against hepatocellular carcinoma, there is still no way to prevent its recurrence. Intrahepatic recurrence can be treated by repeated resection and ablation, and there are many studies showing the advantages and disadvantages of each treatment method. For tumors ≤ 3 cm in diameter, there is no significant difference between surgery resection and radiofrequency/microwave ablation treatment. Non-thermal ablation treatment has clearer borders but a higher postoperative recurrence rate. Percutaneous ethanol injection has comparable efficacy to radiofrequency ablation for small tumors. Multiple recurrences require combined systemic therapy.
Publish Date 2023-04-20 07:26
Citation Wang L, Liu BX, Long HY. Ablative strategies for recurrent hepatocellular carcinoma. World J Hepatol 2023; 15(4): 515-524
URL https://www.wjgnet.com/1948-5182/full/v15/i4/515.htm
DOI https://dx.doi.org/10.4254/wjh.v15.i4.515
Full Article (PDF) WJH-15-515-with-cover.pdf
Full Article (Word) WJH-15-515.docx
Manuscript File 81125_Auto_Edited-JLW.docx
Answering Reviewers 81125-Answering reviewers.pdf
Audio Core Tip 81125-Audio core tip.wav
Conflict-of-Interest Disclosure Form 81125-Conflict-of-interest statement.pdf
Copyright License Agreement 81125-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 81125-Language certificate.pdf
Peer-review Report 81125-Peer-review(s).pdf
Scientific Misconduct Check 81125-Bing-Li L-2.png
Scientific Editor Work List 81125-Scientific editor work list.pdf